Ambu A/S (OTCMKTS:AMBBY) Stock Price Down 2.2% – Time to Sell?

Ambu A/S (OTCMKTS:AMBBY) was down 2.2% during trading on Wednesday . The company traded as low as $15.45 and last traded at $15.45. Approximately 500 shares traded hands during trading, an increase of 71% from the average daily volume of 293 shares. The stock had previously closed at $15.80.

Ambu A/S Price Performance

The stock has a market capitalization of $3.63 billion and a PE ratio of 128.75. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.52 and a quick ratio of 1.51. The firm’s 50 day simple moving average is $18.17 and its 200 day simple moving average is $19.09.

Ambu A/S (OTCMKTS:AMBBY) last issued its earnings results on Friday, August 30th. The company reported $0.07 EPS for the quarter. Ambu A/S had a net margin of 4.30% and a return on equity of 4.09%. The company had revenue of $199.56 million for the quarter.

Ambu A/S Announces Dividend

The business also recently disclosed a dividend, which will be paid on Monday, December 23rd. Stockholders of record on Friday, December 6th will be paid a dividend of $0.0557 per share. The ex-dividend date is Friday, December 6th.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.